Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;73(3):387-394.
doi: 10.1007/s13105-017-0565-1. Epub 2017 Jun 7.

Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats

Ghinwa Barakat  1 , Mohamed E Moustafa  1   2 , Ibrahim Khalifeh  3 , Mohammad H Hodroj  4 , Anwar Bikhazi  5 , Sandra Rizk  6
Affiliations

Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats

Ghinwa Barakat et al. J Physiol Biochem. 2016 Aug.

Erratum in

Abstract

The mechanisms by which exendin-4 and selenium exert their antidiabetic actions are still unclear. Here, we investigated the effects of exendin-4 or selenium administration on the expression of glucagon-like peptide-1 receptor (GLP-1R), insulin receptor substrate-1 (IRS-1), and preproinsulin in the pancreas of diabetic rats. Diabetes was induced by streptozotocin administration. Diabetic rats were injected intraperitoneally with 0.03 μg exendin-4/kg body weight/daily or treated with 5 ppm selenium in drinking water for a period of 4 weeks. GLP-1R and IRS-1 levels were decreased while the level of preproinsulin messenger RNA (mRNA) was increased in the pancreas of diabetic untreated rats, as compared to that in control rats. Treatment of diabetic rats with exendin-4 increased protein and mRNA levels of GLP-1R, and IRS-1, and the mRNA level of preproinsulin in the pancreas, as compared to their levels in diabetic untreated rats. Selenium treatment of diabetic rats increased the pancreatic mRNA levels of GLP-1R, IRS-1, and preproinsulin. Exendin-4 or selenium treatment of diabetic rats also increased the numbers of pancreatic islets and GLP-1R molecules in the pancreas. Therefore, exendin-4 and selenium may exert their antidiabetic effects by increasing GLP-1R, IRS-1, and preproinsulin expression in the pancreas and by increasing the number of pancreatic islets.

Keywords: Antidiabetic; Exendin; GLP-1; Insulin receptor substrate-1; Selenium.

PubMed Disclaimer

References

    1. J Pharmacol Sci. 2009 Dec;111(4):361-71 - PubMed
    1. Biochem Genet. 2012 Dec;50(11-12):922-35 - PubMed
    1. Pharmacol Ther. 2007 Mar;113(3):546-93 - PubMed
    1. Biochim Biophys Acta. 2007 Dec;1772(11-12):1199-210 - PubMed
    1. Prim Care Diabetes. 2008 Jun;2(2):81-5 - PubMed

MeSH terms

LinkOut - more resources